Debananda Das

7PUBLICATIONS
37CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesGenetic immunologyCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 02, 2026
Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main Protease.

Haydar Bulut, Nobuyo Higashi-Kuwata, Hiromi Ogata-Aoki

|Jan 20, 2025
An orally available P1'-5-fluorinated M<sup>pro</sup> inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.

Nobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi

|Jul 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variants.

Manabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut

|Feb 25, 2023
Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.

Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi

|Jan 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Shin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi

|Mar 20, 2019
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.

Hirotomo Nakata, Kenji Maeda, Debananda Das

Pageof 2

Frequent Collaborators

5 joint publications

Hiroaki Mitsuya

5 joint publications

Nobuyo Higashi-Kuwata

5 joint publications

Haydar Bulut

4 joint publications

Yuki Takamatsu